About this paper
In an industry shaped by ever-increasing regulation, global competition and market expectations, research-based biopharmaceutical organizations need ways to improve the efficiency and productivity of drug development processes. Traditional information management practices—constrained by manual data transfer, workflow and audit procedures—are not measuring up. This white paper describes SAS® Drug Development, which provides a unified platform for bringing consistency, control and compliance to information processes, from data aggregation through analysis and reporting to FDA submission.
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 75,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world THE POWER TO KNOW®.